0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rubella ELISA Kits Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29J16550
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rubella ELISA Kits Market Research Report 2024
BUY CHAPTERS

Global Rubella ELISA Kits Market Research Report 2025

Code: QYRE-Auto-29J16550
Report
September 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rubella ELISA Kits Market

The global market for Rubella ELISA Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rubella ELISA Kits refer to Enzyme-Linked Immunosorbent Assay kits used for the detection and quantification of antibodies specific to the Rubella virus. Rubella, also known as German measles, is a highly contagious viral infection that can cause birth defects in pregnant women and serious complications in non-immune individuals. These ELISA kits utilize specific antigen-antibody interactions to detect the presence of Rubella-specific antibodies in patient samples, such as blood serum or plasma. The kits typically include pre-coated microplates, Rubella antigen, detection antibodies, and necessary reagents, allowing for sensitive and specific detection of Rubella antibodies and aiding in diagnostic procedures.
The industry trend for Rubella ELISA Kits is on a positive trajectory due to various factors. Firstly, the emphasis on preventive healthcare and immunization programs worldwide has created a demand for diagnostic tools that can accurately detect Rubella infection and immunity. Additionally, the increase in international travel and migration has raised concerns about the spread of Rubella, necessitating screening and surveillance methods. Moreover, advancements in technology and the development of more sensitive and specific Rubella ELISA kits contribute to the growth of the market. Overall, the industry trend demonstrates a rising demand for Rubella ELISA kits, driven by the need for effective detection and control of Rubella infections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rubella ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella ELISA Kits.
The Rubella ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rubella ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rubella ELISA Kits Market Report

Report Metric Details
Report Name Rubella ELISA Kits Market
Segment by Type
  • IgM
  • IgG
Segment by Application
  • Laboratory
  • Colleges
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MyBioSource, BosterBio, Novus Biologicals, Abbexa, IBL- America, DEMEDITEC Diagnostics, Abnova Corporation, Biorbyt, United States Biological, XpressBio, Wuhan Fine Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rubella ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rubella ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rubella ELISA Kits Market report?

Ans: The main players in the Rubella ELISA Kits Market are MyBioSource, BosterBio, Novus Biologicals, Abbexa, IBL- America, DEMEDITEC Diagnostics, Abnova Corporation, Biorbyt, United States Biological, XpressBio, Wuhan Fine Biotech

What are the Application segmentation covered in the Rubella ELISA Kits Market report?

Ans: The Applications covered in the Rubella ELISA Kits Market report are Laboratory, Colleges, Others

What are the Type segmentation covered in the Rubella ELISA Kits Market report?

Ans: The Types covered in the Rubella ELISA Kits Market report are IgM, IgG

1 Rubella ELISA Kits Market Overview
1.1 Product Definition
1.2 Rubella ELISA Kits by Type
1.2.1 Global Rubella ELISA Kits Market Value Comparison by Type (2024 VS 2031)
1.2.2 IgM
1.2.3 IgG
1.3 Rubella ELISA Kits by Application
1.3.1 Global Rubella ELISA Kits Market Value by Application (2024 VS 2031)
1.3.2 Laboratory
1.3.3 Colleges
1.3.4 Others
1.4 Global Rubella ELISA Kits Market Size Estimates and Forecasts
1.4.1 Global Rubella ELISA Kits Revenue 2020-2031
1.4.2 Global Rubella ELISA Kits Sales 2020-2031
1.4.3 Global Rubella ELISA Kits Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rubella ELISA Kits Market Competition by Manufacturers
2.1 Global Rubella ELISA Kits Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rubella ELISA Kits Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rubella ELISA Kits Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rubella ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rubella ELISA Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rubella ELISA Kits, Product Type & Application
2.7 Global Key Manufacturers of Rubella ELISA Kits, Date of Enter into This Industry
2.8 Global Rubella ELISA Kits Market Competitive Situation and Trends
2.8.1 Global Rubella ELISA Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rubella ELISA Kits Players Market Share by Revenue
2.8.3 Global Rubella ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rubella ELISA Kits Market Scenario by Region
3.1 Global Rubella ELISA Kits Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rubella ELISA Kits Sales by Region: 2020-2031
3.2.1 Global Rubella ELISA Kits Sales by Region: 2020-2025
3.2.2 Global Rubella ELISA Kits Sales by Region: 2026-2031
3.3 Global Rubella ELISA Kits Revenue by Region: 2020-2031
3.3.1 Global Rubella ELISA Kits Revenue by Region: 2020-2025
3.3.2 Global Rubella ELISA Kits Revenue by Region: 2026-2031
3.4 North America Rubella ELISA Kits Market Facts & Figures by Country
3.4.1 North America Rubella ELISA Kits Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rubella ELISA Kits Sales by Country (2020-2031)
3.4.3 North America Rubella ELISA Kits Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rubella ELISA Kits Market Facts & Figures by Country
3.5.1 Europe Rubella ELISA Kits Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rubella ELISA Kits Sales by Country (2020-2031)
3.5.3 Europe Rubella ELISA Kits Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rubella ELISA Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Rubella ELISA Kits Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rubella ELISA Kits Sales by Region (2020-2031)
3.6.3 Asia Pacific Rubella ELISA Kits Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rubella ELISA Kits Market Facts & Figures by Country
3.7.1 Latin America Rubella ELISA Kits Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rubella ELISA Kits Sales by Country (2020-2031)
3.7.3 Latin America Rubella ELISA Kits Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rubella ELISA Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Rubella ELISA Kits Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rubella ELISA Kits Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rubella ELISA Kits Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rubella ELISA Kits Sales by Type (2020-2031)
4.1.1 Global Rubella ELISA Kits Sales by Type (2020-2025)
4.1.2 Global Rubella ELISA Kits Sales by Type (2026-2031)
4.1.3 Global Rubella ELISA Kits Sales Market Share by Type (2020-2031)
4.2 Global Rubella ELISA Kits Revenue by Type (2020-2031)
4.2.1 Global Rubella ELISA Kits Revenue by Type (2020-2025)
4.2.2 Global Rubella ELISA Kits Revenue by Type (2026-2031)
4.2.3 Global Rubella ELISA Kits Revenue Market Share by Type (2020-2031)
4.3 Global Rubella ELISA Kits Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rubella ELISA Kits Sales by Application (2020-2031)
5.1.1 Global Rubella ELISA Kits Sales by Application (2020-2025)
5.1.2 Global Rubella ELISA Kits Sales by Application (2026-2031)
5.1.3 Global Rubella ELISA Kits Sales Market Share by Application (2020-2031)
5.2 Global Rubella ELISA Kits Revenue by Application (2020-2031)
5.2.1 Global Rubella ELISA Kits Revenue by Application (2020-2025)
5.2.2 Global Rubella ELISA Kits Revenue by Application (2026-2031)
5.2.3 Global Rubella ELISA Kits Revenue Market Share by Application (2020-2031)
5.3 Global Rubella ELISA Kits Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MyBioSource
6.1.1 MyBioSource Company Information
6.1.2 MyBioSource Description and Business Overview
6.1.3 MyBioSource Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MyBioSource Rubella ELISA Kits Product Portfolio
6.1.5 MyBioSource Recent Developments/Updates
6.2 BosterBio
6.2.1 BosterBio Company Information
6.2.2 BosterBio Description and Business Overview
6.2.3 BosterBio Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BosterBio Rubella ELISA Kits Product Portfolio
6.2.5 BosterBio Recent Developments/Updates
6.3 Novus Biologicals
6.3.1 Novus Biologicals Company Information
6.3.2 Novus Biologicals Description and Business Overview
6.3.3 Novus Biologicals Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novus Biologicals Rubella ELISA Kits Product Portfolio
6.3.5 Novus Biologicals Recent Developments/Updates
6.4 Abbexa
6.4.1 Abbexa Company Information
6.4.2 Abbexa Description and Business Overview
6.4.3 Abbexa Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbexa Rubella ELISA Kits Product Portfolio
6.4.5 Abbexa Recent Developments/Updates
6.5 IBL- America
6.5.1 IBL- America Company Information
6.5.2 IBL- America Description and Business Overview
6.5.3 IBL- America Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.5.4 IBL- America Rubella ELISA Kits Product Portfolio
6.5.5 IBL- America Recent Developments/Updates
6.6 DEMEDITEC Diagnostics
6.6.1 DEMEDITEC Diagnostics Company Information
6.6.2 DEMEDITEC Diagnostics Description and Business Overview
6.6.3 DEMEDITEC Diagnostics Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.6.4 DEMEDITEC Diagnostics Rubella ELISA Kits Product Portfolio
6.6.5 DEMEDITEC Diagnostics Recent Developments/Updates
6.7 Abnova Corporation
6.7.1 Abnova Corporation Company Information
6.7.2 Abnova Corporation Description and Business Overview
6.7.3 Abnova Corporation Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abnova Corporation Rubella ELISA Kits Product Portfolio
6.7.5 Abnova Corporation Recent Developments/Updates
6.8 Biorbyt
6.8.1 Biorbyt Company Information
6.8.2 Biorbyt Description and Business Overview
6.8.3 Biorbyt Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biorbyt Rubella ELISA Kits Product Portfolio
6.8.5 Biorbyt Recent Developments/Updates
6.9 United States Biological
6.9.1 United States Biological Company Information
6.9.2 United States Biological Description and Business Overview
6.9.3 United States Biological Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.9.4 United States Biological Rubella ELISA Kits Product Portfolio
6.9.5 United States Biological Recent Developments/Updates
6.10 XpressBio
6.10.1 XpressBio Company Information
6.10.2 XpressBio Description and Business Overview
6.10.3 XpressBio Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.10.4 XpressBio Rubella ELISA Kits Product Portfolio
6.10.5 XpressBio Recent Developments/Updates
6.11 Wuhan Fine Biotech
6.11.1 Wuhan Fine Biotech Company Information
6.11.2 Wuhan Fine Biotech Description and Business Overview
6.11.3 Wuhan Fine Biotech Rubella ELISA Kits Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Wuhan Fine Biotech Rubella ELISA Kits Product Portfolio
6.11.5 Wuhan Fine Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rubella ELISA Kits Industry Chain Analysis
7.2 Rubella ELISA Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rubella ELISA Kits Production Mode & Process Analysis
7.4 Rubella ELISA Kits Sales and Marketing
7.4.1 Rubella ELISA Kits Sales Channels
7.4.2 Rubella ELISA Kits Distributors
7.5 Rubella ELISA Kits Customer Analysis
8 Rubella ELISA Kits Market Dynamics
8.1 Rubella ELISA Kits Industry Trends
8.2 Rubella ELISA Kits Market Drivers
8.3 Rubella ELISA Kits Market Challenges
8.4 Rubella ELISA Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Rubella ELISA Kits Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rubella ELISA Kits Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rubella ELISA Kits Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rubella ELISA Kits Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rubella ELISA Kits Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rubella ELISA Kits Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rubella ELISA Kits Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rubella ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rubella ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rubella ELISA Kits, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rubella ELISA Kits, Product Type & Application
 Table 12. Global Key Manufacturers of Rubella ELISA Kits, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rubella ELISA Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella ELISA Kits as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rubella ELISA Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rubella ELISA Kits Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rubella ELISA Kits Sales Market Share by Region (2020-2025)
 Table 19. Global Rubella ELISA Kits Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rubella ELISA Kits Sales Market Share by Region (2026-2031)
 Table 21. Global Rubella ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rubella ELISA Kits Revenue Market Share by Region (2020-2025)
 Table 23. Global Rubella ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rubella ELISA Kits Revenue Market Share by Region (2026-2031)
 Table 25. North America Rubella ELISA Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rubella ELISA Kits Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rubella ELISA Kits Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rubella ELISA Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rubella ELISA Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rubella ELISA Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rubella ELISA Kits Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rubella ELISA Kits Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rubella ELISA Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rubella ELISA Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rubella ELISA Kits Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rubella ELISA Kits Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rubella ELISA Kits Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rubella ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rubella ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rubella ELISA Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rubella ELISA Kits Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rubella ELISA Kits Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rubella ELISA Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rubella ELISA Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rubella ELISA Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rubella ELISA Kits Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rubella ELISA Kits Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rubella ELISA Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rubella ELISA Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rubella ELISA Kits Sales (K Units) by Type (2020-2025)
 Table 51. Global Rubella ELISA Kits Sales (K Units) by Type (2026-2031)
 Table 52. Global Rubella ELISA Kits Sales Market Share by Type (2020-2025)
 Table 53. Global Rubella ELISA Kits Sales Market Share by Type (2026-2031)
 Table 54. Global Rubella ELISA Kits Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rubella ELISA Kits Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rubella ELISA Kits Revenue Market Share by Type (2020-2025)
 Table 57. Global Rubella ELISA Kits Revenue Market Share by Type (2026-2031)
 Table 58. Global Rubella ELISA Kits Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Rubella ELISA Kits Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Rubella ELISA Kits Sales (K Units) by Application (2020-2025)
 Table 61. Global Rubella ELISA Kits Sales (K Units) by Application (2026-2031)
 Table 62. Global Rubella ELISA Kits Sales Market Share by Application (2020-2025)
 Table 63. Global Rubella ELISA Kits Sales Market Share by Application (2026-2031)
 Table 64. Global Rubella ELISA Kits Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rubella ELISA Kits Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rubella ELISA Kits Revenue Market Share by Application (2020-2025)
 Table 67. Global Rubella ELISA Kits Revenue Market Share by Application (2026-2031)
 Table 68. Global Rubella ELISA Kits Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Rubella ELISA Kits Price (US$/Unit) by Application (2026-2031)
 Table 70. MyBioSource Company Information
 Table 71. MyBioSource Description and Business Overview
 Table 72. MyBioSource Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. MyBioSource Rubella ELISA Kits Product
 Table 74. MyBioSource Recent Developments/Updates
 Table 75. BosterBio Company Information
 Table 76. BosterBio Description and Business Overview
 Table 77. BosterBio Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BosterBio Rubella ELISA Kits Product
 Table 79. BosterBio Recent Developments/Updates
 Table 80. Novus Biologicals Company Information
 Table 81. Novus Biologicals Description and Business Overview
 Table 82. Novus Biologicals Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novus Biologicals Rubella ELISA Kits Product
 Table 84. Novus Biologicals Recent Developments/Updates
 Table 85. Abbexa Company Information
 Table 86. Abbexa Description and Business Overview
 Table 87. Abbexa Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Abbexa Rubella ELISA Kits Product
 Table 89. Abbexa Recent Developments/Updates
 Table 90. IBL- America Company Information
 Table 91. IBL- America Description and Business Overview
 Table 92. IBL- America Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. IBL- America Rubella ELISA Kits Product
 Table 94. IBL- America Recent Developments/Updates
 Table 95. DEMEDITEC Diagnostics Company Information
 Table 96. DEMEDITEC Diagnostics Description and Business Overview
 Table 97. DEMEDITEC Diagnostics Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. DEMEDITEC Diagnostics Rubella ELISA Kits Product
 Table 99. DEMEDITEC Diagnostics Recent Developments/Updates
 Table 100. Abnova Corporation Company Information
 Table 101. Abnova Corporation Description and Business Overview
 Table 102. Abnova Corporation Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Abnova Corporation Rubella ELISA Kits Product
 Table 104. Abnova Corporation Recent Developments/Updates
 Table 105. Biorbyt Company Information
 Table 106. Biorbyt Description and Business Overview
 Table 107. Biorbyt Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biorbyt Rubella ELISA Kits Product
 Table 109. Biorbyt Recent Developments/Updates
 Table 110. United States Biological Company Information
 Table 111. United States Biological Description and Business Overview
 Table 112. United States Biological Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. United States Biological Rubella ELISA Kits Product
 Table 114. United States Biological Recent Developments/Updates
 Table 115. XpressBio Company Information
 Table 116. XpressBio Description and Business Overview
 Table 117. XpressBio Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. XpressBio Rubella ELISA Kits Product
 Table 119. XpressBio Recent Developments/Updates
 Table 120. Wuhan Fine Biotech Company Information
 Table 121. Wuhan Fine Biotech Description and Business Overview
 Table 122. Wuhan Fine Biotech Rubella ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Wuhan Fine Biotech Rubella ELISA Kits Product
 Table 124. Wuhan Fine Biotech Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Rubella ELISA Kits Distributors List
 Table 128. Rubella ELISA Kits Customers List
 Table 129. Rubella ELISA Kits Market Trends
 Table 130. Rubella ELISA Kits Market Drivers
 Table 131. Rubella ELISA Kits Market Challenges
 Table 132. Rubella ELISA Kits Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rubella ELISA Kits
 Figure 2. Global Rubella ELISA Kits Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rubella ELISA Kits Market Share by Type: 2024 & 2031
 Figure 4. IgM Product Picture
 Figure 5. IgG Product Picture
 Figure 6. Global Rubella ELISA Kits Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Rubella ELISA Kits Market Share by Application: 2024 & 2031
 Figure 8. Laboratory
 Figure 9. Colleges
 Figure 10. Others
 Figure 11. Global Rubella ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Rubella ELISA Kits Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Rubella ELISA Kits Sales (2020-2031) & (K Units)
 Figure 14. Global Rubella ELISA Kits Average Price (US$/Unit) & (2020-2031)
 Figure 15. Rubella ELISA Kits Report Years Considered
 Figure 16. Rubella ELISA Kits Sales Share by Manufacturers in 2024
 Figure 17. Global Rubella ELISA Kits Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Rubella ELISA Kits Players: Market Share by Revenue in Rubella ELISA Kits in 2024
 Figure 19. Rubella ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Rubella ELISA Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Rubella ELISA Kits Sales Market Share by Country (2020-2031)
 Figure 22. North America Rubella ELISA Kits Revenue Market Share by Country (2020-2031)
 Figure 23. United States Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Rubella ELISA Kits Sales Market Share by Country (2020-2031)
 Figure 26. Europe Rubella ELISA Kits Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Rubella ELISA Kits Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Rubella ELISA Kits Revenue Market Share by Region (2020-2031)
 Figure 34. China Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Rubella ELISA Kits Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Rubella ELISA Kits Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Rubella ELISA Kits Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Rubella ELISA Kits Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Rubella ELISA Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Rubella ELISA Kits by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Rubella ELISA Kits by Type (2020-2031)
 Figure 53. Global Rubella ELISA Kits Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Rubella ELISA Kits by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Rubella ELISA Kits by Application (2020-2031)
 Figure 56. Global Rubella ELISA Kits Price (US$/Unit) by Application (2020-2031)
 Figure 57. Rubella ELISA Kits Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart